Exchange: NYSE·Updated 10:06 AM EDT
EVH logo

EVHEvolent Health Inc - Ordinary Shares - Class A

$5.89
$0.04
(0.68%)
Today
EarningsAug 6
Mkt Cap$667.01M
Vol71,737.00
News
all
press releases
Healthcare IT is the Next AI Growth Story: 3 Stocks to Buy Now
Healthcare IT is emerging as AI's next growth story as providers adopt AI to cut costs & improve care. Here we present three stocks that are likely to benefit.
Zacks
News Placeholder
More News
News Placeholder
American Well (AMWL) Soars 11.1%: Is Further Upside Left in the Stock?
American Well (AMWL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks
News Placeholder
Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026
Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026 Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026 PR Newswire WASHINGTON, July 8, 2026 WASHINGTON, July 8, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused...
PR Newswire
News Placeholder
Should You Buy Evolent Health (EVH) After Golden Cross?
Is it a good or bad thing when a stock experiences a golden cross technical event?
Zacks
News Placeholder
Strength Seen in Evolent Health (EVH): Can Its 9.5% Jump Turn into More Strength?
Evolent Health (EVH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Zacks
News Placeholder
Veeva's Falcon and Vault AI: When Could AI Become a Revenue Driver?
VEEV's Falcon and Vault AI deepen workflow automation across life sciences, while management expects AI revenues to remain immaterial in fiscal 2027.
Zacks
News Placeholder
Quest Analytics Expands Leadership Team with Appointment of Chris Lance as Chief Product Officer
Quest Analytics Expands Leadership Team with Appointment of Chris Lance as Chief Product Officer Quest Analytics Expands Leadership Team with Appointment of Chris Lance as Chief Product Officer PR...
PR Newswire
News Placeholder
Compared to Estimates, Evolent Health (EVH) Q1 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Evolent Health (EVH) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks
News Placeholder
Evolent Health (EVH) Reports Q1 Loss, Misses Revenue Estimates
Evolent Health (EVH) delivered earnings and revenue surprises of +57.17% and -6.68%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Evolent Announces First Quarter 2026 Results
Evolent Announces First Quarter 2026 Results Evolent Announces First Quarter 2026 Results PR Newswire WASHINGTON, May 7, 2026 WASHINGTON, May 7, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH...
PR Newswire
<
1
2
...
>

Advertisement|Remove ads.